Submitted By on February 12, 2014 - 01:12 PM

Manhattan, NY- Feb 12, 2014 – (Techsonian) – U.S. stocks ended Tuesday with solid increases as Federal Reserve Chairwoman Janet Yellen pledged to keep interest rates low and to continue to taper the pace of bond purchases if the economy keeps improving. Heading into the session, many participants were anxious to hear Janet Yellen’s first testimony as the new Fed Chair, but the lengthy appearance before the House Financial Services Committee was largely uneventful.

The Dow Jones Industrial Average locked up 192.98 points, or 1.2%, at 15,994.77 after briefly covering 16,000.

The Nasdaq Composite finished the day 42.87 points, or 1%, higher at 4,191.04.

The S&P 500 index ended up 19.91 points, or 1.1% at 1,819.75.

GW PHARMACEUTICALS (GWPRF) a biopharmaceutical company, along with its subsidiaries, is involved in discovering, developing, and commercializing cannabinoid prescription medicines. The organization works through three segments: Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development.

GW PHARMACEUTICALS (OTCMKTS:GWPRF) ended higher 5.01% and complete the day at $5.41. The total number of shares changed hands during the day was 112,338. After opening at $5.14, the stock hit as high as $5.55. However, it traded between $0.58 and $5.55 over the last twelve months.

For How Long GWPRF will fight for Profitability? Read This Trend Analysis report

HEALTHNOSTICS (HNSS) declared that in combination with its revamped MedBioWeb operation, it is starting, a new medical marijuana and recreational cannabis consumer website paying attention on product information, dispensary locator and resources. The new site will permit customers and patients to recognize, rate and discover legal marijuana dispensaries and compare experiences and products.

HEALTHNOSTICS (OTCMKTS:HNSS) closed yesterday at $0.0019, a -40.62% decrease. Around 56.14 million shares were traded, beating an-average trading volume of 48.26 million shares. The company is now valued at around $1,900.

Has HNSS Found The Bottom And Ready To Gain Momentum? Find Out Here

BAYERISCHE MOTOREN W (BAMXY) along with its subsidiaries involves in the manufacture and sale of cars and motorcycles internationally. The organization’s automotive segment develops, manufactures, accumulates, and sells cars and off-road vehicles under the BMW, MINI, and Rolls-Royce brands, as well as provides spare parts and accessories.

BAYERISCHE MOTOREN W(OTCMKTS:BAMXY) moved 3.19 percent higher at $38.45 and traded between $37.89 and $38.50 after opening the day at $37.96. Its performance over the last five days remained 6.13%, which stands at 1% for a month. Going back further than one month, 1-year performance after recent close was -2.49%.

For How Long BAMXY Gloss will Attract Investors? Find out via this report

CYNAPSUS THERAPEUTIC (CYNAF) a unique pharmaceutical firm reported that in January, 125,324 warrants with an exercise price of $0.575 have been exercised for total proceeds of $72,062. Following the exercise of these warrants, Cynapsus has 39,009,335 commons shares, 21,426,439 warrants and 2,691,316 options to purchase common shares outstanding.

CYNAPSUS THERAPEUTIC (OTCMKTS:CYNAF) shares rose, gaining 16.76 percent to close at $0.911. The stock is up around 26.82% this year and 1813.24% for the last 12 months. Around 693,114 shares changed hands yesterday, higher from an-average trading volume of 193,248 shares.

Why Should Investors Buy CYNAF After The Recent Gain? Just Go Here and Find Out